Assess the Efficacy and Safety of INCB054707 in Participants

With Hidradenitis Suppurativa

ID# NCT04476043


Recruitment Status: Recruiting

Estimated Study Completion Date: July 28, 2022

HS Connect listed this: September 2020


Sponsor: Incyte Corporation

Information provided by (Responsible Party): Incyte Corporation


Brief Summary:


To evaluate the efficacy and safety of INCB054707 in participants with hidradenitis suppurativa over a 16-week placebo-controlled treatment period followed by a 36 -week open-label extension period.


Please link for complete trial details:


Location: Multiple US locations. Please see link provided above for all location details and to confirm your location is recruiting.


Contact Information: 


Contact: Incyte Corporation Call Center (US) Phone: 1.855.463.3463 Email:


Contact: Incyte Corporation Call Center (ex-US) Phone: +800 00027423 Email:


© 2021 by HS Connect, LLC  |  |  PO Box 73244 Puyallup, WA 98373  |  253.256.1579